N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142067 |
| CAS No | NA |
| Mol.F. | C15H15N5O2 |
| Mol.Wt. | 297.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142068 |
| CAS No | NA |
| Mol.F. | C12H9N5O2 |
| Mol.Wt. | 255.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142069 |
| CAS No | NA |
| Mol.F. | C19H22N4O7 |
| Mol.Wt. | 418.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142070 |
| CAS No | NA |
| Mol.F. | C25H26N4O7 |
| Mol.Wt. | 494.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142071 |
| CAS No | NA |
| Mol.F. | C26H32N4O7 |
| Mol.Wt. | 512.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142072 |
| CAS No | NA |
| Mol.F. | C23H23ClN4O4 |
| Mol.Wt. | 454.91 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142073 |
| CAS No | NA |
| Mol.F. | C22H21BrN4O4 |
| Mol.Wt. | 485.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142074 |
| CAS No | NA |
| Mol.F. | C18H20N4O |
| Mol.Wt. | 308.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142075 |
| CAS No | NA |
| Mol.F. | C18H18N4O2 |
| Mol.Wt. | 322.37 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142076 |
| CAS No | NA |
| Mol.F. | C13H11N3O6S |
| Mol.Wt. | 337.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142077 |
| CAS No | NA |
| Mol.F. | C13H12N2O4S |
| Mol.Wt. | 292.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142078 |
| CAS No | NA |
| Mol.F. | C21H25N3O7 |
| Mol.Wt. | 431.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142079 |
| CAS No | NA |
| Mol.F. | C18H19N3O7 |
| Mol.Wt. | 389.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142080 |
| CAS No | NA |
| Mol.F. | C24H20N4O4 |
| Mol.Wt. | 428.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142081 |
| CAS No | NA |
| Mol.F. | C11H15N3O |
| Mol.Wt. | 205.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142082 |
| CAS No | NA |
| Mol.F. | C20H20N4O5 |
| Mol.Wt. | 396.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |